In Brief: Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific: Names Philip Le Goff, PhD, group president, Vascular Businesses (Meadox, Medi-tech and Target Therapeutics). Le Goff formerly served as head of strategy and public affairs at Novartis Pharma AG as a member of its global executive committee. Boston Scientific also names Michel Darnaud president of Boston Scientific Europe. Darnaud formerly served as president-Europe for Baxter International's Cardiovascular Group. Delays in executing Boston Scientific's European business strategy contributed to lower-than-expected third quarter results, the company states ("The Gray Sheet" Sept. 15, I&W-10)...